Catalyst Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell
Catalyst Pharmaceuticals (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for patients living with rare diseases, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Patrick J. McEnany, Chairman and CEO of Catalyst, rings the Closing Bell.